男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Chinadaily.com.cn
 
Go Adv Search

Novo Nordisk has innovative prescription for expansion

Updated: 2011-11-02 14:27

By Liu Jie (China Daily)

  Comments() Print Mail Large Medium  Small

Novo Nordisk has innovative prescription for expansion

Lars Rebien Sorensen, president and chief executive officer of Novo Nordisk A/S. [Photo/ China Daily]

BEIJING - The world's largest insulin producer, Novo Nordisk A/S, said it would not pursue mergers and acquisitions (M&A) in China but would instead expand by strengthening its research and development (R&D) activity, building manufacturing facilities and enhancing education.

"A few multinational companies made acquisitions (in China) to get entry into the generic medication and (over-the-counter) business.

"Novo Nordisk is another kind of company. We want to concentrate on innovative new drugs," Ronald Frank Christie, senior vice-president of Novo Nordisk and president of Novo Nordisk (China) Pharmaceuticals Co Ltd, said on Monday.

According to Lars Rebien Sorensen, president and chief executive officer of Novo Nordisk A/S, the Denmark-based company has made "substantial" investments in China in R&D, manufacturing and education.

He said the company will "continue to invest in the emerging market, also the fastest-growing market for Novo Nordisk".

The drugmaker, which has focused on diabetes for more than 80 years, said last year it would invest more than $100 million to expand its R&D center in Beijing and double its R&D staff to 200 within five years.

The center in Beijing is Novo Nordisk's largest such facility outside its headquarters in Copenhagen.

"We are not interested in bringing in generic (products). We are only interested in bringing new drugs to the market, to make a difference," said Christie.

Novo Nordisk, which produces two-thirds of the insulin used in China, also announced in 2008 it would invest $400 million to build a manufacturing base in Tianjin, which is expected to go into full operation in 2012. That base would be the largest manufacturing facility for the company outside its home market of Denmark.

In addition to meeting local demand, the Tianjin base will also export products.

"We believe that the capacity of manufacturing (in Tianjin) will supply our demand at least for the next three or four years," said Sorensen. "Perhaps, two years from now, we may have to consider further investment, but it's too early to talk about that."

Novo Nordisk has sought to provide consumer education and offer training to local doctors. In addition to constant community-training courses, it linked up with the Ministry of Health and Chinese academic institutes to hold international diabetes forums and train grassroots medical care practitioners.

Statistics from the Ministry of Health show that nearly 100 million Chinese have diabetes. The Chinese diabetes drug market will increase to more than $2.8 billion by 2015 from $642 million in 2009, the International Market Analysis Research and Consulting Group said in a report.

According to medical care research company IMS Health, Novo Nordisk, US-based Eli Lilly and Co and French drugmaker Sanofi AS hold about 90 percent of China's insulin market.

Some international pharmaceutical companies, such as Swiss drugmaker Novartis AG and Novo Nordisk's archrival Sanofi, were engaged in M&As with local companies in recent years.

"Different companies have different choices, given their different competitive edges.

"Innovation-focused drug producers in China may face the challenge of high prices compared with generic products and difficulties in getting their products on the nation's essential drug list or into the medical insurance system," said Guo Fanli, an analyst from the domestic research company China Investment Consulting.

 

主站蜘蛛池模板: 乐至县| 太原市| 应城市| 奉新县| 鹰潭市| 乡宁县| 天长市| 车险| 高青县| 宝清县| 加查县| 邵东县| 无为县| 濮阳县| 苏州市| 盱眙县| 四子王旗| 美姑县| 陆川县| 三门峡市| 崇明县| 清河县| 寿阳县| 桐庐县| 斗六市| 安徽省| 永川市| 高平市| 十堰市| 和硕县| 全南县| 南陵县| 竹山县| 鹤庆县| 隆安县| 衡阳市| 密山市| 金溪县| 牙克石市| 五大连池市| 班玛县| 怀来县| 开远市| 洮南市| 合阳县| 南靖县| 黑水县| 西乌| 万全县| 梧州市| 云南省| 南投县| 大同市| 石台县| 吴江市| 徐州市| 哈巴河县| 北安市| 辽宁省| 大洼县| 历史| 孟州市| 潜山县| 成安县| 溆浦县| 平乡县| 渝中区| 浑源县| 唐河县| 曲靖市| 刚察县| 宜川县| 廊坊市| 安达市| 洪湖市| 雷波县| 贺兰县| 巩义市| 绥宁县| 弋阳县| 固安县| 祥云县|